The technology focuses on the delivery of subunit vaccines via mucosal surfaces, such as via a nasal spray. A recent study reports that the vaccine technology provides robust protection against infections with the coronavirus and influenza virus.
Aina Anthi (front) and Anette Kolderup (behind) at Oslo University Hospital are two of the researchers involved in developing the new vaccine technology. Photo: Mari Nyquist-Andersen.
/University of Oslo Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
